BCL 6 (lymphoma-associated transcription factor), MUM1/IRF4 (multiple myeloma ocongene-1/interferon regulatory factor 4), and MIB1/Ki-67 (marker of cellular proliferation) are tumor markers associated with a higher risk for disseminated disease [56]. This evidence concerns the gene IRF4 and plasma cell myeloma.